Iowa House Bill HF2563

Iowa 2025-2026 Regular Session

• Introduced: 2/16/26
• Refer: 3/19/26

Caption

A bill for an act relating to abortions including informed consent, dispensing abortion-inducing drugs, and reporting abortion-inducing drug complications.(Formerly HSB 704; See HF 2788.)

Impact

The bill introduces significant changes to the regulatory framework surrounding abortion procedures within the state. It enforces stricter definitions and guidelines for chemical abortions, and mandates that healthcare facilities and physicians report complications related to the use of abortion-inducing drugs. This report must include various details such as the patient's age, residency, and the specific complications encountered. The emphasis on reporting aims to enhance patient safety and understand the impacts of chemical abortions better, thereby potentially influencing state health policies and practices regarding reproductive health.

Summary

House File 2563 aims to amend existing laws related to abortions by establishing stricter informed consent protocols, detailed reporting requirements for complications arising from abortion-inducing drugs, and specific conditions under which such drugs can be dispensed. Notably, the bill specifies that a physician must conduct an in-person examination of the patient before performing an abortion and must inform the patient of the risks associated with abortion-inducing drugs. This also includes advising patients on emergency interventions should complications arise post-abortion.

Contention

Contention around HF2563 centers on the implications of increased regulation on women's access to abortion services and the autonomy of healthcare providers. Supporters argue that these measures are essential for ensuring patient safety and informed decision-making. Critics, however, contend that such regulations may hinder access to abortion services and could place undue burdens on both providers and patients. The provisions regarding informed consent and emergency intervention may also invoke debate regarding the adequacy of care and support available to women considering this option.